益丰药房控股股东和高管减持后，又有两名高管拟套现

Core Viewpoint - Yifeng Pharmacy (603939) announced a share reduction plan by senior management, indicating potential liquidity needs among executives [1] Group 1: Management Share Reduction - Vice Presidents Wang Yonghui and Xiao Zaixiang plan to reduce their holdings by a total of no more than 213,900 shares through centralized bidding [1] - As of now, Wang Yonghui holds 601,440 shares and Xiao Zaixiang holds 254,760 shares [1] Group 2: Previous Reductions - The controlling shareholder and three senior executives have already completed share reduction plans this year [1] - From August 5 to August 6, 2025, the controlling shareholder, Houxin Chuangtou, and its concerted parties reduced their holdings by 24,248,200 shares, accounting for 2.00% of the total share capital [1] - Executives Gao Youcheng and Yan Jun reduced their holdings by 50,400 shares and 22,900 shares respectively between February 24 and May 23, 2025 [1] - Vice President Zhang Zhaoxu reduced his holdings by 20,200 shares through centralized bidding on January 2, 2025 [1] Group 3: Share Price Range - The reduction prices for the aforementioned shareholders and executives ranged from 22 yuan to 25 yuan [1]